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Abstract
Background: Most patients have favorable outcomes after primary total knee arthroplasty (TKA). Well-validated
methods to predict the risk of poor outcomes have not been developed or implemented. Several patients have
annual clinic visits despite well-funcitoning TKA, as a routine practice, to detect early failure requiring revision
surgery. It is not known whether assessment of pain and function can be used as a predictive tool for early failure
and revision to guide practice. Our objective was to determine whether pain and function can predict revision after
TKA.
Methods: We retrospectively studied data from a large prospectively gathered TKA registry to examine changes in
outcome scores for primary TKAs undergoing revision compared to those not requiring revision to determine the
factors that are predictive for revision.
Results: Of the 1,012 patients, 721 had had a single-sided primary TKA and had American Knee Society (AKS) Scores
for three or more visits. 46 patients underwent revision, 23 acutely (fracture, traumatic component failure or acute
infection) and 23 for latent causes (late implant loosening, progressive osteolysis, or pain and indolent infection). Mean
age was 70 years for the non-revision patients, and 64 years for those revised. Both AKS Clinical and AKS Function
Scores for non-revised patients were higher than in revision patients, higher in acute revision compared to latent
revision patients. Significant predictors of revision surgery were preoperative, 3- and 15-month postoperative AKS
Clinical Scores and 3-month AKS Function Scores. At 15-month post-TKA, a patient with a low calculated probability of
revision, 32 % or less, was unlikely to require revision surgery with a negative predictive value of 99 %.
Conclusion: Time dependent interval evaluation post-TKA with the AKS outcome scores may provide the ability to
assign risk of revision to patients at the 15-month follow-up visit. If these findings can be replicated using a patient-
reported measure, a virtual follow-up with patient-reported outcomes and X-ray review may be an alternative to clinic
visit for patients doing well.
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Background
The demand for total joint arthroplasty is expected to
increase significantly by the year 2020 in the US and
other countries [1]. Such volume will invariably increase
the need for both surgical resources and the resources
required to follow these patients over time. Survivorship
for modern total knee arthroplasty (TKA) has generally
been reported at 15 years or more with an estimated in-
cidence of failure of 1 % per year [1–3]. Although the
most appropriate protocol for following the TKA patient
has not been established, an American Association of
Hip and Knee Surgeons (AAHKS) survey advocates
biannual or annual clinic follow-up visits even for
asymptomatic patients after primary TKA [4]. These
visits routinely include a radiographic evaluation and an
associated physical exam by an orthopaedic surgeon or
qualified provider. One major motivation for longitu-
dinal surveillance is the early identification of clinically
significant osteolysis in the asymptomatic patient.
Total knee failures for fracture, component failure or
acute infection tend to be painful and typically motivate pa-
tients to seek prompt clinical evaluation. The latent causes
of revision including osteolysis or pain are more insidious
and require surveillance by the clinician. Timely interven-
tion for osteolysis has been shown to reduce the overall
cost and length of recovery after surgery [5]. Although sev-
eral studies have used logistic regression modeling to pre-
dict variables that impact outcome after arthroplasty
surgery [6–9], to our knowledge no study has generated a
predictive equation for determining the probability of revi-
sion using only outcome scores.
The use of outcome measures in arthroplasty research
has focused on investigating the epidemiology of arthro-
plasty patients, identifying patient risk factors leading to
poor clinical outcomes, determining implant survival
and quantifying patient experience and satisfaction. One
example of such an outcome instrument is the American
Knee Society (AKS) Clinical Rating System [10].
Understanding the long-term results of joint arthro-
plasty can help surgeons improve both their ability to
make the correct decision regarding the need for surgery
as well as the technical competence required for a suc-
cessful procedure [11]. Can outcome measurements be
used as a predictive tool to guide our surveillance prac-
tices? Are there specific time intervals after surgery that
predict the need for revision surgery? Can a population-
specific equation be generated to calculate probability
for revision surgery?
The purpose of this study was to assess the relationship
between chronological changes in AKS scores with an end
point of revision surgery. We hypothesized that patients
with a total knee arthroplasty can be categorized as one of
the following: 1) the acutely failed TKA, 2) the TKA at risk
of latent failure, or 3) the well-functioning TKA.
Furthermore, we hypothesize that these populations can
be distinguished by changes in AKS scores over time, in-
dependent of information gained from the physician office
visit. The following research questions were investigated
in this study for a patient population with TKA:
1. On average, at what point did the patients undergo
revision surgery after the primary surgery?
2. Do patients with or without revision have statistically
different AKS Clinical scores over time?
3. Do patients with or without revision have statistically
different AKS Function scores over time?
4. What independent variables are statistically
significant predictors of whether patients will
undergo revision surgery?
Methods
One thousand and twelve consecutive patients who
underwent TKA at the Minneapolis Veteran’s Affairs
(VA) Arthroplasty TKA registry were retrospectively
reviewed from 1993 to 2008. Of the 1012 patients in the
database, 721 patients met all of the following inclusion
criteria for analysis: 1) the American Knee Society (AKS)
Scores were available for three or more visits, 2) the
AKS Scores fit within the appropriate 0 to 100 scale, and
3) patients with a single-sided primary total knee arthro-
plasty. The sample of 721 patients included 46 patients
who ultimately underwent revision arthroplasty and 675
non-revision patients. The average age of all of the pa-
tients in the study (n = 721) was 69 years. The average
age of the non-revision patients (n = 675) was 70 years,
and the average age of the patients who underwent revi-
sion TKA (n = 46) was 64 years. Twenty-three knees
were revised for fracture, traumatic component failure
or acute infection. These were categorized as acute
causes for revision. The remaining 23 knees were revised
for implant loosening, progressive osteolysis, or pain and
indolent infection categorized as latent causes for revi-
sion. AKS scores were assessed from the preoperative
visit and subsequent postoperative follow-up visits.
Data were collected on the 721 patients including age
at primary surgery, AKS Clinical Scores, and AKS Func-
tion Scores. For the 46 revision patients, the time inter-
val in months between the primary surgery and revision
surgery was also collected. Visits were scheduled at
regular intervals for all patients, but were altered as
needed to accommodate patient needs. In order to per-
form logistic regression modeling focusing on changes
in the AKS scores, time intervals were normalized for
patients at 3-month time intervals from 0 months
(preoperative visit) until 48 months. We considered but
decided not to have smaller intervals than 3-months,
since regular pain/function assessments are typically not
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done any more frequently than 3-monthly. All patients
had a minimal follow-up of 12-months.
The AKS is a disease-specific, provider-administered
outcome instrument developed in 1989. Designed as a
dual rating system– evaluating the knee arthroplasty
separate from the patient’s functional status [10]– the
developers of the AKS sought to isolate arthroplasty-
specific changes from those global changes in a patient’s
health and function attributable to aging. AKS Clinical
scores are generated from 100 points possible with de-
ductions for pain, malalignment, and limited ROM.
Importantly, a high AKS Clinical score reflects less pain.
The AKS Functional score is a 100 point index with de-
ductions for limitation in walking and use of stairs, and
for the use of assistive devices and/or railings. When
compared to the Western Ontario Mcmaster osteoarth-
ritis Index (WOMAC) and Short-Form-36 (SF-36), the
AKS demonstrates acceptable construct validity, reliabil-
ity and responsiveness [12, 13]. Normative values for the
AKS in the elderly have been established for general
control comparison [14]. The AKS provides information
that is non-specific for unilateral versus bilateral total
knee arthroplasty. Although the AKS Score was recently
extensively revised, tested, and released for use in early
2012, most arthroplasty surgeons have had more experi-
ence with the earlier version described.
Missing data points were calculated using the one of the
following rules: 1) existing data was entered if the visit oc-
curred within one month of the 3-month time interval, 2)
values were imputed if one time interval was missing be-
tween two intervals where existing data was present and
had the same values (<20 % were imputed), 3) values were
calculated using individual patient regression model esti-
mates for revision patients, and 4) values were calculated
following the trends for the individual patient’s scores.
Individual patient regression models were used to calcu-
late missing interval data for revision patients because the
data had curvilinear and linear trends. Since data on average
tended to be flat in patients without revision, regression
models were not used. After the data was filled in using the
first two rules, the regression model data were entered for
the patients with revision. The regression estimates needed
to fit within the range of data that were entered for the sur-
rounding two time intervals or it was not used.
The final method used to calculate interval data was
to use the average of the scores that surrounded the
missing data point. For example, if the AKS Clinical
Scores were available for 9 months at 50 and 15 months
at 70, then the estimate for 12 months would be 60. Re-
vision patients’ data included intervals after revision to
complete the 48-month period.
Statistical tests were conducted using SPSS v20. Trend
analyses were conducted for the AKS Function Scores and
Clinical Scores of the patients over time. Comparisons of
the means across different groups of patients were also
conducted using analysis of variance (ANOVA) tests.
Post-hoc analysis was performed with the Student-
Newman-Keuls test. In addition, a stepwise hierarchical
logistic regression was used to identify the statistically sig-
nificant predictors of the probability of revision surgery.
This generated an equation to determine the probability
of revision TKA. Patients were classified as high or low
risk for revision based on their calculated probability for
revision TKA.
Results
Average time of revision surgery in patients with TKA
The average time between primary surgery and revision
surgery is 3.1 years (range = 0.4 years to 11.8 years). Ap-
proximately 19.6 % of patients had revision surgery less
than a year after their primary surgery, 54.3 % of patients
had revision surgery between 1–4 years after primary sur-
gery, and 26.1 % of patients had revision surgery more
than 4 years after their primary surgery. A range of 0–4
years accounts for 74 % of all revisions surgeries. The
figures show the association of AKS clinical score with
overall revision risk (Fig. 1) and the risk of revision type,
early vs. latent vs. none (Fig. 2) and of AKS function score
with overall revision (Fig. 3) and revision type (Fig. 4).
Statistically significant predictors of the probability of
revision surgery
Binary logistic regression analyses were conducted to de-
termine the statistically significant predictors of the
probability of revision surgery. Variables included 1) age
Fig. 1 AKS Clinical Score over time for patients with revisions (n = 46)
and patients without revisions (n = 675). ANOVA showed no difference
in the AKS Clinical scores between groups at 0 months (Student-
Newman-Keuls P > 0.05). There was no difference in AKS Clinical scores
between the latent and acute groups at 3–18 months, but the non-
revision group differed significantly from both the latent and acute
groups at these time intervals (p = 0.05)
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of the patients, 2) AKS Clinical Scores 3) AKS Function
Scores. Multiple regression models were generated to
determine the optimal model to predict the probability
of having revision surgery with the most clinical applic-
ability. Clinical applicability was targeted at a model with
the highest predictive value using variables closest to the
time of primary surgery. The following four independent
variables were found to be significant predictors of revi-
sion: AKS Pain Score at 0 months (p. < 0.0001), AKS
Clinical Score at 3 months (p < 0.0001), AKS Clinical
Score at 15 months (p < 0.0001), and AKS Function
Score at 3 months (p = 0.004, Table 1).
The optimal logistic regression equation model for our
TKA Registry is:
Log oddsRevision Surgery ¼ 0:703 þ 0:113 ðAKS Clinical
Scores for 0 monthsÞ
– 0:156 AKS Clinical Scoresð
at 3 monthsÞ
– 0:107 AKS Clinical Scoresð
at 15 monthsÞ
þ 0:043 AKS Function Scoresð
at 3 monthsÞ
When applied to the revision group, the average calcu-
lated probability from this equation is 59 % (standard
deviation [SD] +/- 20 %). The average probability is 4 %
(SD +/- 14 %) for the non-revision group. Two standard
deviations above the patient without revisions mean
would include a range from 0–32 %. The range for high
risk for revision surgery was selected as 32 % or greater.
Using this range, patients requiring revision surgery are
predicted with a sensitivity of 89 % and specificity of
96 % (Additional file 1). The positive predictive value of
this range is 63 %. The negative predictive value for pa-
tients identified as low risk to not undergo surgery is
99 % (Additional file 1). If a patient’s calculated probabil-
ity for revision is less than 32 % at the 15 month visit,
they are highly unlikely to require revision surgery by
the 4 years post-operative visit. Examples of the use of
the prediction equation are shown in Additional file 1.
Discussion
As the demand for primary total joint arthroplasties
continues to increase, alternate means of longitudinal
follow-up will be necessary. What information should be
collected from our patients, and at what time interval re-
mains a topic of discussion. In this retrospective review
of 1,012 total knee arthroplasties we found that the
probability of requiring revision surgery could be calcu-
lated using AKS data from 3 critical postoperative time
intervals: 0, 3, and 15 months. This model can account
for 67 % of the variance concerning the probability of
the patients needing revision surgery. This model effect-
ively discriminated between revision and non-revision
patients. The age of the patient at the time of revision
and the length of time between primary surgery and re-
vision were not significant predictors for revision sur-
gery. Our findings provide further support to previous
findings that Oxford knee and hip scores at 6-months
and Oxford hip scores at 5-years were predictive of sub-
sequent early revision [15, 16]. A recent UK study
showed that review of questionnaire and radiograph
Fig. 2 AKS Clinical Score over time for patients with acute revisions (n
= 23), patients with latent revisions (n = 23), and patients without
revisions (n = 675). All 3 groups had significantly different AKS Clinical
scores at the 21–48 month time intervals (p = 0.05)
Fig. 3 AKS Function Score over time for patients with revisions (n = 46)
and patients without revisions (n = 675). ANOVA showed that there was
no difference in the AKS Function scores for any of the 3 groups at 0–21
months (p =0.83). From 24–48 months, the acute and latent revision
group were not statistically different (Student-Newman-Keuls p >0.05)
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together (but not either alone) identified all patients in
need of increased surveillance after TKA/THA [17]. Our
findings of association of pain/function scores with revi-
sion risk are similar to these previous studies. An ad-
vance from our study is the development of a prediction
model using scores from validated questionnaires.
The proposed prediction equation would require AKS to
be measured preoperatively and at 3 and 15 months post-
TKA (at least two office visits). Some providers may only
be following their patients on an as needed basis after the
initial wound check in the first 2–6 weeks post-TKA.
Patient-reported outcome measures may be able to capture
data that were captured in AKS scores (a physician-
administered measure), and may be a more practical
alternative to AKS. Our prediction equation needs to be
replicated using patient-reported outcome measures.
Although consensus recommendations in the US have
favored annual or biannual follow-up [4], this has not
been globally accepted. Bankes and colleagues [18]
reviewed 1000 questionnaires to the British Orthopaedic
Association (BOA) concerning follow-up practices. They
found that 50 % of surgeons followed their total hip pa-
tients less than 1 year. The majority of providers (78 %)
followed them for under 5 years, and only 14 % had in-
definite follow-up. The authors reported that cost was a
major deterrent of annual follow-up for all arthroplasty
patients [18]. In our population, 73.9 % of revisions oc-
curred early and were captured within the first 4 years.
The utility of the physician visit for well functioning
arthroplasties has been questioned. Bhatia and Obadare
[19] performed a cost-benefit analysis of 100 consecutive
patients and found that the 304 visits with radiographs for
100 patients over a 2 year period resulted in a cost of
£23,397 ($38,970 in 2003 USD). There were 10 patients
that had issues requiring interventions, of which three were
found in clinic follow-ups and seven identified by General
Practice referral or in the Emergency Department. They
noted that most issues that required intervention were
found at the first postoperative visit. Their recommenda-
tions were for routine follow-up for 6–12 weeks [19]. The
BOA recommends AP/lateral radiographs at 5 years and
every 5 years thereafter for long-term surveillance (Anon.
Total Hip Replacement: A Guide to Best Practice 1999).
The British National Health Service also notes the waiting
list time for new arthroplasty patient evaluation as a signifi-
cant consideration for resource utilization [18, 19].
Patient experience and satisfaction have been driving
forces in US healthcare reform and optimization.
Sethuraman surveyed 100 patients during routine arthro-
plasty follow-up about their preference for office visits
Fig. 4 AKS Function Scores for patients with acute revisions (n = 23), patients with latent revisions (n = 23), and patients without revisions (n = 675).
From 24–48 months, the acute revision and non-revision group were also statistically similar. The latent group and the non-revision group
were statistically different (Student-Newman-Keuls p = 0.05)
Table 1 Statistically significant variables that predict the probability of having revision surgery
Independent variables Wald test Significance levela Coefficient (B)
AKS Clinical Score at 0 months 24.616 0.000 0.113
AKS Clinical Score at 3 months 36.301 0.000 −0.156
AKS Clinical Score at 15 months 35.109 0.000 −0.107
AKS Function Score at 3 months 8.369 0.004 0.043
aThe significance level for this study has been set at p-values equal to or less than 0.05
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[20]. A significant proportion (45 %) would have preferred
not to have an office visit, citing wages lost and potential
time spared as determining factors. None of these patients
felt that the quality of their care would be jeopardized by
not having an office visit. It was noted that the remaining
55 % noted that office visits and routinely seeing their sur-
geon was important for maintaining quality of care and
satisfaction. The authors recommended asking patients
their preference and following those not interested in
office follow-up with radiographs and completion of an
outcomes measure.
There are limitations to the conclusions that can be
drawn from the current study. The ability to generalize re-
sults using our population’s logistical regression equation is
limited to use in similar patient populations with unilateral
total knee arthroplasty. Although women represent 66.2 %
of the primary total knee arthroplasty patients receiving a
joint in one year [21], they represent 1 % of this Veterans
Administration arthroplasty patient population. Single-site
study and a low number of revisions limit the
generalizability. Another limitation is the outcome
instrument utilized. This version of the Knee Society Score
itself is not without limitations. It is non-specific in its
reporting of clinical change and function for patients with
bilateral arthroplasties. Lingard and colleagues evaluated
the validity and reliability of the AKS compared to the
WOMAC and SF-36. They found that although the AKS
had adequate convergent construct validity, it had weaker
responsiveness and poor inter-item correlation compared
with either of the other measures [12]. Both the clinical and
function scores reach their maximum improvement at 2-
years, followed by subsequent decline as a function of age
and as the patient’s number of comorbidities increase [22].
Konig and colleagues prospectively evaluated 276 TKA pa-
tients and found that after clinical scores and functional
scores plateaued, they tended to decrease by 5 points/year
after 2 years postoperative [22]. A notable weakness of this
study is the need to normalize the time intervals for gener-
ating the regression models required to compare the revi-
sion patients’ AKS scores. We realize that standard clinic
follow up visits likely occurs at 2 weeks, 6 weeks, 3 months,
6 months and 1 year after the arthroplasty. In order to
optimize comparisons of the trends of each individual des-
pite variability of follow-up intervals, we utilized rules to
calculate intervening scores. The validity of our conclusions
are clearly related to the assumptions made.
Our study predicts the risk of revision only, recogniz-
ing that interventions other than revision may be needed
by some patients post-TKA. Future studies should exam-
ine non-revision interventions as well.
Although this study can act as a basis for future com-
parisons, validation of the prediction equation could occur
by repeating this study with an increased number of visits
at 3 month intervals for 48 months. This may be costly
and impractical. Validation could also take the form of
replicating the techniques used here to evaluate similar
TKA registries that have collected AKS scores over time.
Further research is needed to evaluate other arthroplasty
outcome instruments for their ability to predict revision at
associated critical time intervals. It may also be important
to determine if regression modeling can assist in risk
stratification for patients following revision surgery, identi-
fying risk for further additional surgical interventions.
Interestingly, the preoperative AKS scores did vary signifi-
cantly between revision and non-revision groups. Previous
studies have shown that preoperative differences in de-
pression, pain and anxiety, and gender are predictive
of poor outcome following total knee arthroplasty
[23–25]. Future research can be directed at quantifying
the utility of using preoperative AKS scores to identify pa-
tients at risk for poor outcome prior to surgery. Latent
and acute revision subgroups were both statistically differ-
ent from each other, and from the non-revision group.
Due to the low number of patients in each of these sub-
groups it was impossible to create logistical regression
equations to predict membership in each of these groups.
As we continue to follow our cohort and identify more
members in these groups, further analysis can be per-
formed to describe predictive implications.
Conclusions
In conclusion, we noted that patients with and without re-
visions have AKS scores that vary significantly over time.
Specifically, patients with revisions can be viewed in terms
of their mechanism of failure, and patients with latent and
acute revisions have statistically different AKS score pro-
files. The change in AKS scores at set time intervals can
be used to calculate the risk of revision vs. non-revision.
Risk stratification can provide an objective guide for sur-
veillance practices. Our data suggest that using the AKS
Score gathered preoperatively, at 3 months and 15 months
postoperatively can aid in understanding an individual pa-
tient’s probability for revision. This may provide a power-
ful incentive for surgeons to participate in arthroplasty
registries which include gathering such outcome measure-
ments. Follow-up care guided by risk stratification offers a
potential reduction in resource expenditure for the pa-
tient, the surgeon, and the medical system.
Additional file
Additional file 1: Appendix 1. Tabulation of patients who did and did
not have revision surgery and thier risk of revision. This supplementary
file shows the cross-tabulation of the patients determined to be high- or
low-risk based on the equation, who underwent revision surgery. Appendix
2: Interpretation using the Equation with examples. This supplementary file
shows two examples of risk of revision in two hypothetical patents with
regards to the risk of revision surgery and the proposed clinkical surveillance
frequency based on the risk of revision. (DOC 80 kb)




This material is the result of work supported by the facilities and resources at the
Minneapolis and the Birmingham Veterans affairs medical centers. No additional
funding was obtained to conduct this study.
Availability of data and materials
We will share the data with anyone interested once they meet the data
privacy and HIPAA regulations.
Authors’ contributions
CH, LH, PM, TG and JS were responsible for the conception of study. CH, PM
and TG developed study protocol and methods, and all authors provided
comments. CH and LH were responsible for data acquisition and PT
performed data analyses. CH and LH wrote the first draft of the paper. All
authors were responsible for review and interpretation of data, revision of
the manuscript, the decision to submit it and the approval of the final
version of the manuscript.
Competing interests
There are no financial conflicts directly related to this work. JAS has received
research grants from Takeda and Savient and consultant fees from Savient,
Takeda, Regeneron, Merz, Bioiberica, Crealta and Allergan pharmaceuticals,
WebMD, UBM LLC and the American College of Rheumatology. JAS serves as the
principal investigator for an investigator-initiated study funded by Horizon
pharmaceuticals through a grant to DINORA, Inc., a 501 (c)(3) entity. JAS is a
member of the executive of OMERACT, an organization that develops outcome
measures in rheumatology and receives arms-length funding from 36 companies;
a member of the American College of Rheumatology’s (ACR) Annual Meeting
Planning Committee (AMPC); Chair of the ACR Meet-the-Professor, Workshop and
Study Group Subcommittee; and a member of the Veterans Affairs Rheumatology
Field Advisory Committee. Other authors declare no relevant financial conflict.
None of the authors have any non-financial conflict.
“The views expressed in this article are those of the authors and do not
necessarily reflect the position or policy of the Department of Veterans
Affairs or the United States government.”
Consent for publication
Not applicable.
Ethics approval and consent to participate
The study was approved by the Institutional Review Board (IRB) at the
Minneapolis Veterans Affairs medical center. The IRB waived the need for
patient consent for this study, since this was a retrospecitve database
analysis. Each author certifies that his or her institution has approved the
human protocol for this investigation and that all investigations were
conducted in conformity with ethical principles of research.
Author details
1Alaska Native Medical Center, Anchorage, AK, USA. 2Department of
Agricultural and Extension Education, Virginia Tech, Blacksburg, VA, USA.
3Health East Education and Research Department, St. Paul, MN, USA.
4Department of Orthopaedic Surgery, University of MN Medical School,
Minneapolis, MN, USA. 5Department of Orthopaedic Surgery, Minneapolis
VAMC, Minneapolis, MN, USA. 6Birmingham VAMC and University of Alabama
at Birmingham, Faculty Office Tower 805B, 510 20th Street S, Birmingham, AL
35294, USA.
Received: 3 September 2015 Accepted: 12 August 2016
References
1. Kurtz SM, Ong KL, Lau E, Bozic KJ. Impact of the economic downturn on
total joint replacement demand in the United States: updated projections
to 2021. J Bone Joint Surg Am. 2014;96(8):624–30.
2. Labek G, Thaler M, Janda W, Agreiter M, Stockl B. Revision rates after total
joint replacement: cumulative results from worldwide joint register datasets.
J Bone Joint Surg (Br). 2011;93(3):293–7.
3. Nemes S, Rolfson O, W-Dahl A, Garellick G, Sundberg M, Karrholm J, et al.
Historical view and future demand for knee arthroplasty in Sweden. Acta
Orthop. 2015;86(4):426–31.
4. Teeny SM, York SC, Mesko JW, Rea RE. Long-term follow-up care
recommendations after total hip and knee arthroplasty: results of the
American Association of Hip and Knee Surgeons’ member survey. J
Arthroplasty. 2003;18(8):954–62.
5. Lavernia CJ. Cost-effectiveness of early surgical intervention in silent
osteolysis. J Arthroplasty. 1998;13(3):277–9.
6. Tian W, DeJong G, Munin MC, Smout R. Patterns of rehabilitation after hip
arthroplasty and the association with outcomes: an episode of care view.
Am J Phys Med Rehabil. 2010;89(11):905–18.
7. Higuera CA, Elsharkawy K, Klika AK, Brocone M, Barsoum WK. 2010 Mid-
America Orthopaedic Association Physician in Training Award: predictors of
early adverse outcomes after knee and hip arthroplasty in geriatric patients.
Clin Orthop Relat Res. 2011;469(5):1391–400.
8. Wagenmakers R, Stevens M, van den Akker-Scheek I, Zijlstra W, Groothoff
JW. Predictive value of the Western Ontario and McMaster Universities
Osteoarthritis Index for the amount of physical activity after total hip
arthroplasty. Phys Ther. 2008;88(2):211–8.
9. Ong KL, Lau E, Suggs J, Kurtz SM, Manley MT. Risk of subsequent revision
after primary and revision total joint arthroplasty. Clin Orthop Relat Res.
2010;468(11):3070–6.
10. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical
rating system. Clin Orthop Relat Res. 1989;248:13–4.
11. Callaghan JJ, Johnston RC, Pedersen DR. The John Charnley Award. Practice
surveillance: a practical method to assess outcome and to perform clinical
research. Clin Orthop Relat Res. 1999;369:25–38.
12. Lingard EA, Katz JN, Wright RJ, Wright EA, Sledge CB. Validity and
responsiveness of the Knee Society Clinical Rating System in
comparison with the SF-36 and WOMAC. J Bone Joint Surg Am. 2001;
83-A(12):1856–64.
13. Kreibich DN, Vaz M, Bourne RB, Rorabeck CH, Kim P, Hardie R, et al. What is
the best way of assessing outcome after total knee replacement? Clin
Orthop Relat Res. 1996;331:221–5.
14. Bremner-Smith AT, Ewings P, Weale AE. Knee scores in a ‘normal’ elderly
population. Knee. 2004;11(4):279–82.
15. Rothwell AG, Hooper GJ, Hobbs A, Frampton CM. An analysis of the Oxford
hip and knee scores and their relationship to early joint revision in the New
Zealand Joint Registry. J Bone Joint Surg (Br). 2010;92(3):413–8.
16. Devane P, Horne G, Gehling DJ. Oxford hip scores at 6 months and 5 years
are associated with total hip revision within the subsequent 2 years. Clin
Orthop Relat Res. 2013;471(12):3870–4.
17. Kingsbury SR, Dube B, Thomas CM, Conaghan PG, Stone MH. Is a
questionnaire and radiograph-based follow-up model for patients with
primary hip and knee arthroplasty a viable alternative to traditional regular
outpatient follow-up clinic? Bone Joint J. 2016;98-B(2):201–8.
18. Bankes MJ, Coull R, Ferris BD. How long should patients be followed-up
after total hip replacement? Current practice in the UK. Ann R Coll Surg
Engl. 1999;81(5):348–51.
19. Bhatia M, Obadare Z. An audit of the out-patient follow-up of hip and knee
replacements. Ann R Coll Surg Engl. 2003;85(1):32–5.
20. Sethuraman V, McGuigan J, Hozack WJ, Sharkey PF, Rothman RH. Routine
follow-up office visits after total joint replacement: do asymptomatic
patients wish to comply? J Arthroplasty. 2000;15(2):183–6.
21. Mahomed NN, Barrett J, Katz JN, Baron JA, Wright J, Losina E. Epidemiology
of total knee replacement in the United States Medicare population. J Bone
Joint Surg Am. 2005;87(6):1222–8.
22. Konig A, Scheidler M, Rader C, Eulert J. The need for a dual rating system in
total knee arthroplasty. Clin Orthop Relat Res. 1997;345:161–7.
23. Brander VA, Stulberg SD, Adams AD, Harden RN, Bruehl S, Stanos SP, et al.
Predicting total knee replacement pain: a prospective, observational study.
Clin Orthop Relat Res. 2003;416:27–36.
24. Brander V, Gondek S, Martin E, Stulberg SD. Pain and depression influence
outcome 5 years after knee replacement surgery. Clin Orthop Relat Res.
2007;464:21–6.
25. Parsley BS, Bertolusso R, Harrington M, Brekke A, Noble PC. Influence of
gender on age of treatment with TKA and functional outcome. Clin Orthop
Relat Res. 2010;468(7):1759–64.
Hightower et al. BMC Health Services Research  (2016) 16:429 Page 7 of 7
